{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:29:30Z","timestamp":1787923770818,"version":"build-2784847793"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.msard.2026.107361","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:44:09Z","timestamp":1782949449000},"page":"107361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Multiple sclerosis during an emergency or crisis: A narrative review focused on the effect of war and COVID-19 pandemic"],"prefix":"10.1016","volume":"113","author":[{"given":"Masoud","family":"Etemadifar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehri","family":"Salari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1861-7063","authenticated-orcid":false,"given":"Fatemeh","family":"Hojjatipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.msard.2026.107361_bib0001","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1080\/14737175.2021.1957673","article-title":"Understanding and managing the impact of the Covid-19 pandemic and lockdown on patients with multiple sclerosis","volume":"21","author":"Abbadessa","year":"2021","journal-title":"Expert Rev. Neurother"},{"issue":"11","key":"10.1016\/j.msard.2026.107361_bib0002","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1007\/s10072-023-07052-9","article-title":"Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based Study","volume":"44","author":"Affinito","year":"2023","journal-title":"Neurol Sci"},{"issue":"1","key":"10.1016\/j.msard.2026.107361_bib0003","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13031-025-00695-9","article-title":"Chronic disease patients during the armed conflict in Sudan: a cross-sectional study on mental health and quality of life","volume":"19","author":"Ahmed","year":"2025","journal-title":"Confl. Health"},{"issue":"1","key":"10.1016\/j.msard.2026.107361_bib0004","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13031-025-00679-9","article-title":"War and chronic illness: a health center-based study of Palestinians with non-communicable diseases in Gaza","volume":"19","author":"Aldabbour","year":"2025","journal-title":"Confl. Health"},{"issue":"16_supplement","key":"10.1016\/j.msard.2026.107361_bib0005","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.88.16_supplement.P3.338","article-title":"The impact of the Syrian war on multiple sclerosis (MS) patients (P3.338)","volume":"88","author":"Almallouhi","year":"2017","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.msard.2026.107361_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-025-13366-9","article-title":"Wartime stress and relapse risk in people with multiple sclerosis: a prospective cohort study","volume":"272","author":"Aloni","year":"2025","journal-title":"J. Neurol"},{"issue":"10","key":"10.1016\/j.msard.2026.107361_bib0007","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3390\/ijerph22101555","article-title":"Violence, inequity, and their impact on health and access to healthcare services among the elderly population of Bogot\u00e1","volume":"22","author":"Cano-Guti\u00e9rrez","year":"2025","journal-title":"IJERPH"},{"key":"10.1016\/j.msard.2026.107361_bib0008","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbi.2015.06.019","article-title":"Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound","volume":"50","author":"Cavone","year":"2015","journal-title":"Brain Behav. Immun"},{"key":"10.1016\/j.msard.2026.107361_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.613769","article-title":"Multiple sclerosis patient management during the COVID-19 pandemic: practical recommendations from the Portuguese multiple sclerosis study group (GEEM)","volume":"12","author":"Cerqueira","year":"2021","journal-title":"Front Neurol"},{"issue":"2","key":"10.1016\/j.msard.2026.107361_bib0010","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/13548506.2021.1939072","article-title":"Managing chronic disease in the COVID-19 pandemic: an e-learning application to promote a healthy lifestyle for persons with multiple sclerosis","volume":"27","author":"d\u2019Arma","year":"2022","journal-title":"Psychol. Health Med"},{"issue":"12","key":"10.1016\/j.msard.2026.107361_bib0011","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41582-022-00735-5","article-title":"Social determinants of health in multiple sclerosis","volume":"18","author":"Dobson","year":"2022","journal-title":"Nat. Rev. Neurol"},{"issue":"1","key":"10.1016\/j.msard.2026.107361_bib0012","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/00912174241272680","article-title":"PTSD symptoms among patients with multiple sclerosis in Jordan during October 7th Gaza war outbreak","volume":"60","author":"Gammoh","year":"2025","journal-title":"Int. J. Psychiatry Med"},{"issue":"4","key":"10.1016\/j.msard.2026.107361_bib0013","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2058","article-title":"Neurological symptoms in Covid-19 patients in the emergency department","volume":"11","author":"Garc\u00eda-Azor\u00edn","year":"2021","journal-title":"Brain Behav"},{"issue":"2","key":"10.1016\/j.msard.2026.107361_bib0014","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ana.21409","article-title":"Impact of exposure to war stress on exacerbations of multiple sclerosis","volume":"64","author":"Golan","year":"2008","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.msard.2026.107361_bib0015","series-title":"Crisis, Displacement, and Resilience: The Impact of the October 7th War on Recipients of Community Mental Health Rehabilitation in Israel [Internet]","author":"Grotto","year":"2025"},{"issue":"9","key":"10.1016\/j.msard.2026.107361_bib0016","first-page":"1936","article-title":"Disaster and multiple sclerosis: a systematic review","volume":"51","author":"HabibiSaravi","year":"2022","journal-title":"Iran. J. Public Health"},{"issue":"8","key":"10.1016\/j.msard.2026.107361_bib0017","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000037297","article-title":"Review of multiple sclerosis: epidemiology, etiology, pathophysiology, and treatment","volume":"103","author":"Haki","year":"2024","journal-title":"Medicine"},{"key":"10.1016\/j.msard.2026.107361_bib0018","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2147\/TCRM.S257714","article-title":"Managing disease-modifying therapies and breakthrough activity in multiple sclerosis patients during the COVID-19 pandemic: toward an optimized approach","volume":"16","author":"Hamdy","year":"2020","journal-title":"TCRM"},{"issue":"7","key":"10.1016\/j.msard.2026.107361_bib0019","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/jamaneurol.2016.0826","article-title":"Rebound syndrome in patients with multiple sclerosis after cessation of fingolimod treatment","volume":"73","author":"Hatcher","year":"2016","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.msard.2026.107361_bib0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-014749","article-title":"The 12 dimensions of health impacts of war (the 12-D framework): a novel framework to Conceptualise impacts of war on social and environmental determinants of health and public health","volume":"9","author":"Jayasinghe","year":"2024","journal-title":"BMJ Glob. Health"},{"key":"10.1016\/j.msard.2026.107361_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1273916","article-title":"Healthcare bias and health inequalities towards displaced Syrians in Lebanon: a qualitative study","volume":"11","author":"Khalifeh","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.msard.2026.107361_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1024046","article-title":"The impact of the war on maintenance of long-term therapies in Ukraine","volume":"13","author":"Khanyk","year":"2022","journal-title":"Front. Pharmacol"},{"key":"10.1016\/j.msard.2026.107361_bib0023","series-title":"Procuring Health Equity: Treatment Activists Fighting for Access to Medicines in Ukraine","author":"Lawlor","year":"2024"},{"key":"10.1016\/j.msard.2026.107361_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104531","article-title":"Healthcare complexities during community crises: recommendation for access to healthcare for Australians with multiple sclerosis","volume":"71","author":"Learmonth","year":"2023","journal-title":"Mult. Scler. Relat. Disord"},{"issue":"3","key":"10.1016\/j.msard.2026.107361_bib0025","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/1355819620975069","article-title":"Impact of the COVID-19 pandemic on persons with multiple sclerosis: early findings from a survey on disruptions in care and self-reported outcomes","volume":"26","author":"Manacorda","year":"2021","journal-title":"J. Health V Res. Policy"},{"key":"10.1016\/j.msard.2026.107361_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105085","article-title":"Indirect impact of the COVID-19 pandemic on the care and outcomes of people with MS: a combined survey and insurance claims study","volume":"80","author":"Meltzer","year":"2023","journal-title":"Mult. Scler. Relat. Disord"},{"issue":"10","key":"10.1016\/j.msard.2026.107361_bib0027","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1177\/1352458520948231","article-title":"Multiple sclerosis management during the COVID-19 pandemic","volume":"26","author":"Moss","year":"2020","journal-title":"Mult Scler"},{"issue":"4","key":"10.1016\/j.msard.2026.107361_bib0028","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/13623699.2021.1971824","article-title":"The social determinants of health and health seeking behaviour in populations affected by armed conflict: a qualitative systematic review","volume":"37","author":"Munezero","year":"2021","journal-title":"Med. Confl. Surviv"},{"issue":"22","key":"10.1016\/j.msard.2026.107361_bib0029","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1212\/WNL.0b013e31821e7c8a","article-title":"Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis","volume":"76","author":"O\u2019Connor","year":"2011","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.msard.2026.107361_bib0030","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/hex.13284","article-title":"They\u2019re getting a taste of our world\u2019: a qualitative study of people with multiple sclerosis\u2019 experiences of accessing health care during the COVID-19 pandemic in the Australian capital territory","volume":"24","author":"Parkinson","year":"2021","journal-title":"Health Expect"},{"issue":"1","key":"10.1016\/j.msard.2026.107361_bib0031","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/13524585211005339","article-title":"Impact of COVID-19 on multiple sclerosis care and management: results from the European committee for treatment and research in multiple sclerosis survey","volume":"28","author":"Portaccio","year":"2022","journal-title":"Mult Scler"},{"issue":"1","key":"10.1016\/j.msard.2026.107361_bib0032","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/13524585211005339","article-title":"Impact of COVID-19 on multiple sclerosis care and management: results from the European committee for treatment and research in multiple sclerosis survey","volume":"28","author":"Portaccio","year":"2022","journal-title":"Mult Scler"},{"key":"10.1016\/j.msard.2026.107361_bib0033","doi-asserted-by":"crossref","unstructured":"Prosperini L, Arrambide G, Celius EG, Goletti D, Killestein J, Kos D, et al. COVID-19 and multiple sclerosis: challenges and lessons for patient care. The lancet regional health - Europe. 2024;44:100979. doi:10.1016\/j.lanepe.2024.100979.","DOI":"10.1016\/j.lanepe.2024.100979"},{"key":"10.1016\/j.msard.2026.107361_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102798","article-title":"Fear and anxiety in patients with multiple sclerosis during COVID-19 pandemic; report of an Iranian population","volume":"50","author":"Ramezani","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107361_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577627","article-title":"Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: an international consensus statement","volume":"357","author":"Reyes","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2026.107361_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577627","article-title":"Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: an international consensus statement","volume":"357","author":"Reyes","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2026.107361_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106726","article-title":"The association between the use of digital platforms in multiple sclerosis patients\u2019 healthcare and MS fellowships\u2019 perspective regarding the Israel-Iran war impact on MS disease","volume":"104","author":"Rezaeimanesh","year":"2025","journal-title":"Mult. Scler. Relat. Disord"},{"key":"10.1016\/j.msard.2026.107361_bib0038","doi-asserted-by":"crossref","unstructured":"Rog D, Brownlee W, Carod-Artal FJ, Kalra S, Barker N, Lowndes C, et al. Quantifying the administration and monitoring time burden of several disease-modifying therapies for relapsing multiple sclerosis in the United Kingdom: a time and motion study. Multiple sclerosis and related disorders. 2024;82:105380. doi:10.1016\/j.msard.2023.105380.","DOI":"10.1016\/j.msard.2023.105380"},{"issue":"7","key":"10.1016\/j.msard.2026.107361_bib0039","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1007\/s10072-021-05212-3","article-title":"Virtual visits for chronic neurologic disorders during COVID-19 pandemic","volume":"42","author":"Rosellini","year":"2021","journal-title":"Neurol Sci"},{"issue":"2","key":"10.1016\/j.msard.2026.107361_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurop.2024.100154","article-title":"Impact of the COVID-19 pandemic on the physical activity habits of people with multiple sclerosis in Spain","volume":"4","author":"Santoyo-Medina","year":"2024","journal-title":"Neurol. Perspect."},{"issue":"1","key":"10.1016\/j.msard.2026.107361_bib0041","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10916-025-02220-0","article-title":"From conflict to care - telemedicine utilization during wartime: a retrospective cohort study","volume":"49","author":"Sberro-Cohen","year":"2025","journal-title":"J. Med. Syst"},{"key":"10.1016\/j.msard.2026.107361_bib0042","doi-asserted-by":"crossref","unstructured":"Singer BA, Morgan D, Stamm JA, Williams AA. Patient and physician perspectives of treatment burden in multiple sclerosis. neurol ther. 2024;13(6):1507\u201325. doi:10.1007\/s40120-024-00654-1.","DOI":"10.1007\/s40120-024-00654-1"},{"key":"10.1016\/j.msard.2026.107361_bib0043","article-title":"Depression and anxiety in patients with multiple sclerosis treated with interferon-beta or fingolimod: role of indoleamine 2,3-dioxygenase and pro-inflammatory cytokines","volume":"9","author":"Tauil","year":"2020","journal-title":"Brain Behav. Immun Health"},{"issue":"3","key":"10.1016\/j.msard.2026.107361_bib0044","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4103\/aian.AIAN_457_20","article-title":"Integration of Teleneurology within the health system to manage patients of multiple sclerosis and other CNS demyelinating disorders during COVID-19 pandemic","volume":"24","author":"Thomas","year":"2021","journal-title":"Ann. Indian Acad. Neurol"},{"key":"10.1016\/j.msard.2026.107361_bib0045","doi-asserted-by":"crossref","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The lancet neurology. 2018;17(2):162\u201373. doi:10.1016\/S1474-4422(17)30470-2.","DOI":"10.1016\/S1474-4422(17)30470-2"},{"issue":"2","key":"10.1016\/j.msard.2026.107361_bib0046","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.msard.2026.107361_bib0047","doi-asserted-by":"crossref","first-page":"e969","DOI":"10.1016\/S2214-109X(23)00128-6","article-title":"Mental health and psychosocial support in humanitarian settings: research priorities for 2021\u201330","volume":"11","author":"Tol","year":"2023","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.msard.2026.107361_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2025.111854","article-title":"Editors\u2019 choice June 2025","volume":"182","author":"Tovey","year":"2025","journal-title":"J. Clin. Epidemiol"},{"key":"10.1016\/j.msard.2026.107361_bib0049","doi-asserted-by":"crossref","unstructured":"Van Ballegooijen H, van der Hiele K, Enzinger C, de Voer G, Visser LH. The longitudinal relationship between fatigue, depression, anxiety, disability, and adherence with cognitive status in patients with early multiple sclerosis treated with interferon beta-1a. eNeurologicalSci. 2022;28:100409. doi:10.1016\/j.ensci.2022.100409, PubMed PMID: 35733640.","DOI":"10.1016\/j.ensci.2022.100409"},{"key":"10.1016\/j.msard.2026.107361_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102512","article-title":"Impact of the COVID-19 pandemic on the health care of >1,000 People living with multiple sclerosis: a cross-sectional study","volume":"46","author":"Vogel","year":"2020","journal-title":"Mult. Scler. Relat. Disord"},{"issue":"3","key":"10.1016\/j.msard.2026.107361_bib0051","first-page":"153","article-title":"Health and physical activity of ukrzainians during a full-scale war with Russia","volume":"18","author":"Vorobiova","year":"2024","journal-title":"Rehabil. Recreat"},{"issue":"1\u20132","key":"10.1016\/j.msard.2026.107361_bib0052","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jns.2009.10.012","article-title":"The effect of war stress on multiple sclerosis exacerbations and radiological disease activity","volume":"288","author":"Yamout","year":"2010","journal-title":"J. Neurol. Sci"},{"issue":"1\u20132","key":"10.1016\/j.msard.2026.107361_bib0053","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jns.2009.10.012","article-title":"The effect of war stress on multiple sclerosis exacerbations and radiological disease activity","volume":"288","author":"Yamout","year":"2010","journal-title":"J. Neurol. Sci"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826003974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826003974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:52:38Z","timestamp":1787921558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826003974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":53,"alternative-id":["S2211034826003974"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107361","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple sclerosis during an emergency or crisis: A narrative review focused on the effect of war and COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107361","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107361"}}